Trial Profile
Enbrel-JIA Use Results Survey [All-Case Surveillance].
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Nov 2013
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Juvenile rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms Enbrel-JIA
- Sponsors Pfizer
- 01 Oct 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Jun 2013 Planned end date changed from 1 May 2013 to 1 Oct 2013 as reported by ClinicalTrials.gov.
- 30 Jan 2012 Planned end date changed from 1 Dec 2011 to 1 May 2013 as reported by ClinicalTrials.gov.